DEPOMED INC's ticker is DEPO and the CUSIP is 249908104. A total of 201 filers reported holding DEPOMED INC in Q1 2016. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $201,000 | -80.2% | 34,723 | -63.3% | 0.00% | -83.3% |
Q2 2017 | $1,017,000 | +35.4% | 94,649 | +58.2% | 0.01% | +20.0% |
Q1 2017 | $751,000 | +31.3% | 59,816 | +88.5% | 0.01% | +25.0% |
Q4 2016 | $572,000 | -28.5% | 31,731 | -0.9% | 0.00% | -33.3% |
Q3 2016 | $800,000 | +55.0% | 32,031 | +21.9% | 0.01% | +50.0% |
Q2 2016 | $516,000 | +3.6% | 26,281 | -26.6% | 0.00% | 0.0% |
Q1 2016 | $498,000 | -26.3% | 35,781 | -4.0% | 0.00% | -33.3% |
Q4 2015 | $676,000 | -3.8% | 37,281 | 0.0% | 0.01% | -14.3% |
Q3 2015 | $703,000 | -17.5% | 37,281 | -6.0% | 0.01% | -12.5% |
Q2 2015 | $852,000 | -5.3% | 39,681 | -1.2% | 0.01% | -11.1% |
Q1 2015 | $900,000 | +41.1% | 40,181 | +1.5% | 0.01% | +28.6% |
Q4 2014 | $638,000 | +2.4% | 39,591 | -3.4% | 0.01% | -12.5% |
Q3 2014 | $623,000 | +9.3% | 40,991 | 0.0% | 0.01% | +14.3% |
Q2 2014 | $570,000 | -4.0% | 40,991 | 0.0% | 0.01% | -12.5% |
Q1 2014 | $594,000 | +48.1% | 40,991 | +8.0% | 0.01% | +33.3% |
Q4 2013 | $401,000 | – | 37,941 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DELTEC ASSET MANAGEMENT LLC | 2,159,164 | $32,798,000 | 7.35% |
Senvest Management, LLC | 4,515,935 | $68,597,000 | 6.42% |
Broadfin Capital, LLC | 2,313,702 | $35,145,000 | 3.68% |
HAYS ADVISORY LLC | 512,820 | $7,790,000 | 1.03% |
Ghost Tree Capital, LLC | 120,000 | $1,823,000 | 0.99% |
EMERALD MUTUAL FUND ADVISERS TRUST | 647,096 | $9,829,000 | 0.94% |
TURNER INVESTMENTS LLC | 817,177 | $12,413,000 | 0.74% |
EMERALD ADVISERS, LLC | 681,346 | $10,350,000 | 0.62% |
TSP Capital Management Group, LLC | 86,300 | $1,311,000 | 0.60% |
PERKINS CAPITAL MANAGEMENT INC | 38,500 | $585,000 | 0.49% |